124 related articles for article (PubMed ID: 29771175)
1. Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study.
Kathle PK; Gautam N; Kesavan K
J Microencapsul; 2018 May; 35(3):292-300. PubMed ID: 29771175
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imaging.
Nankali E; Shaabanzadeh M; Torbati MB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1211-1219. PubMed ID: 31980856
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR; Bharadwaj M; Madhusudhan B
J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes.
Shaker DS; Shaker MA; Hanafy MS
Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.
Maji R; Dey NS; Satapathy BS; Mukherjee B; Mondal S
Int J Nanomedicine; 2014; 9():3107-18. PubMed ID: 25028549
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Salem HF; Kharshoum RM; Abo El-Ela FI; F AG; Abdellatif KRA
Drug Deliv Transl Res; 2018 Jun; 8(3):633-644. PubMed ID: 29488171
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral Drug: Loaded Hybrid Nanocapsules Based on Chitosan with Potential Effects in Breast Cancer Therapy.
Dellali KZ; Rata DM; Popa M; Djennad M; Ouagued A; Gherghel D
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784525
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
9. Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells.
Chowdhury N; Vhora I; Patel K; Bagde A; Kutlehria S; Singh M
AAPS PharmSciTech; 2018 Oct; 19(7):3287-3297. PubMed ID: 30218267
[TBL] [Abstract][Full Text] [Related]
10. Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers.
Beh CY; How CW; Foo JB; Foong JN; Selvarajah GT; Rasedee A
Drug Des Devel Ther; 2017; 11():771-782. PubMed ID: 28352153
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
[TBL] [Abstract][Full Text] [Related]
12. Application of Box-Behnken Design in the Preparation, Optimization, and In Vitro Evaluation of Self-Assembly-Based Tamoxifen- and Doxorubicin-Loaded and Dual Drug-Loaded Niosomes for Combinatorial Breast Cancer Treatment.
Kulkarni P; Rawtani D
J Pharm Sci; 2019 Aug; 108(8):2643-2653. PubMed ID: 30905701
[TBL] [Abstract][Full Text] [Related]
13. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
14. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the Therapeutic Efficacy of Tamoxifen Citrate Loaded Span-Based Nano-Vesicles on Human Breast Adenocarcinoma Cells.
Kassem MA; Megahed MA; Abu Elyazid SK; Abd-Allah FI; Abdelghany TM; Al-Abd AM; El-Say KM
AAPS PharmSciTech; 2018 May; 19(4):1529-1543. PubMed ID: 29470829
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.
Hashem FM; Nasr M; Khairy A
Pharm Dev Technol; 2014 Nov; 19(7):824-32. PubMed ID: 24032414
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems.
Martínez A; Arana P; Fernández A; Olmo R; Teijón C; Blanco MD
J Microencapsul; 2013; 30(4):398-408. PubMed ID: 23489017
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation.
Reddy LH; Vivek K; Bakshi N; Murthy RS
Pharm Dev Technol; 2006; 11(2):167-77. PubMed ID: 16749527
[TBL] [Abstract][Full Text] [Related]
19. Glycinated fullerenes for tamoxifen intracellular delivery with improved anticancer activity and pharmacokinetics.
Misra C; Kumar M; Sharma G; Kumar R; Singh B; Katare OP; Raza K
Nanomedicine (Lond); 2017 May; 12(9):1011-1023. PubMed ID: 28440713
[TBL] [Abstract][Full Text] [Related]
20. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
